U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07272629) titled 'A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.' on Nov. 26.

Brief Summary: This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.

Study Start Date: Dec. 03

Study Type: INTERVENTIONAL

Condition: Cardiac Repolarization Healthy Volunteers

Intervention: DRUG: Balinatunfib

Pharmaceutical form: Tablet Route of administration: Oral

DRUG: Moxifloxacin

Pharmaceutical form: Tablet Route of administration: Oral

DRUG: Placebo

Pharmaceutical form...